Male patient, fully autonomous in daily activities. He is being accompanied in the heart clinic since the beginning of the year due to ischemic heart failure.

Novartis Netherlands

This action is correct. According to PARADIGM-HF (2016), comparing to enalapril, sacubitril-valsartan was associated to:
- 20% reduction of the risk of cardiovascular death;
- 21% reduction of the risk of first hospitalization due to heart failure decompensation;
- 16% reduction of all cause mortality; 
- reduction of symptoms and NYHA class.

-20% risk of mortality and -21% risk of hospitalization

Sacubitril/Valsartan prescribed

John Mario

Internal medicine 

HF Clinical Case - Mr. John [English]

Training Course in Heart Failure - the clinical case of Mr. John

74 years old, married, fully autonomous in daily activities. Her complaints are fatigue and dyspnea with medium exertion, that limit her daily activities significantly; She also reports episodes of paroxysmal nocturnal dyspnea, orthopnea, increased waist circumference and bilateral lower limb edema of afternoon predominance.

Anne Mary

HF Clinical Case - Ms. Anne Mary [English]

68 years old male, autonomous in activities of daily living, diagnosed with HFrEF (EF 28% in transthoracic echocardiogram of this hospitalization). Committed to the hospital for decompensated HF in the context of a community-acquired right base pneumonia. Currently with only little congestion; hospital discharge is expected quickly. 